8th Annual USC Multidisciplinary Breast Cancer Symposium

 

8th Annual USC Multidisciplinary Breast Cancer Symposium
Avatar

Innovations in Management of mTNBC: PARP Inhibitors

By 8th Annual USC Multidisciplinary Breast Cancer Symposium FEATURING Sara A. Hurvitz
By 8th Annual USC Multidisciplinary Breast Cancer Symposium FEATURING Sara A. Hurvitz
366 views
January 28, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood
Videos
05:35

HR+HER2- High-Risk eBC: Surveying Efficacy Data of CDK4/6i in the Ad…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

193 views
09:19

HR+/HER2- MBC: Outcomes of 1/2L CDK4/6 Inhibition

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

272 views
09:50

ER+ Early Stage BC: Which Patients Should Avoid Chemotherapy? Does C…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

211 views
06:22

PI3K/AKT/mTOR Inhibition in Advanced BC: Is There Any Benefit With A…

8th Annual USC Multidisciplinary Breast Cancer Symposium

G. Sledge

74 views
30:59

Genetic Risk in BC: BRCA1/2 Mutations, Genetic Testing, Preventive B…

8th Annual USC Multidisciplinary Breast Cancer Symposium

B. Arun

28 views
35:08

Oncoplastic Surgery and BC: What Is Extreme Oncoplasty? When Can We …

8th Annual USC Multidisciplinary Breast Cancer Symposium

M. Silverstein

58 views
28:38

Diagnostic MRI for Newly Diagnosed BC: Factors of Occult Lesions Det…

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Sener

480 views
39:07

2021 Challenges in HER2+ BC Testing: IHC Guidelines, Biomarker Testi…

8th Annual USC Multidisciplinary Breast Cancer Symposium

M. Press

60 views
18:27

2021 Updates on HER2+ MBC: What Does the New Data on T-DXd Suggest? …

8th Annual USC Multidisciplinary Breast Cancer Symposium

W. Gradishar

433 views
11:34

2021 Updates on HER2+ MBC: Tucatinib Combo and HRQoL in Brain Mets, …

8th Annual USC Multidisciplinary Breast Cancer Symposium

W. Gradishar

121 views
19:06

USC Update on 1L Chemo Combination for Advanced TNBC: Does the Addit…

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

145 views
06:31

Innovations in Management of mTNBC: PARP Inhibitors

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

366 views
13:11

Clinical Trial Data on ADCs in TNBC: Sacituzumab Govitecan Efficacy …

8th Annual USC Multidisciplinary Breast Cancer Symposium

S. Hurvitz

251 views